Precision medicine: RNA-based diagnostics startup raises $22M Series C
Advanced Cell Diagnostics just raised a $22 million Series C to enter the clinical and research diagnostics space - with aims to be used as a precision medicine tool. It profiles single gene expression in situ, studying the targeted molecular structure of each cell in a sample - and can detect every gene in the human transcriptome, the startup says.